Lido Advisors’s CME Group CME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-700
Closed -$193K 1849
2025
Q2
$193K Buy
+700
New +$190K ﹤0.01% 1531
2024
Q4
Sell
-900
Closed -$199K 1515
2024
Q3
$199K Hold
900
﹤0.01% 1344
2024
Q2
$177K Hold
900
﹤0.01% 1300
2024
Q1
$194K Hold
900
﹤0.01% 1265
2023
Q4
$190K Sell
900
-300
-25% -$64K ﹤0.01% 1229
2023
Q3
$240K Sell
1,200
-1,300
-52% -$258K ﹤0.01% 1012
2023
Q2
$463K Hold
2,500
﹤0.01% 772
2023
Q1
$479K Hold
2,500
﹤0.01% 687
2022
Q4
$420K Sell
2,500
-200
-7% -$34.8K 0.01% 665
2022
Q3
$478K Hold
2,700
0.01% 567
2022
Q2
$552K Buy
2,700
+1,500
+125% +$318K 0.01% 511
2022
Q1
$285K Buy
+1,200
New +$282K ﹤0.01% 828

Other funds holding CME

Lido Advisors's CME Position: Q1 2026 in Review

Lido Advisors increased its CME Group (CME) stake by 9.2% in Q1 2026, buying an estimated $454K and bringing the position to 18,230 shares worth $5.39M. The position accounts for 0.02% of the portfolio, ranked #441.

Lido Advisors first reported a position in CME in Q3 2017 and has held it in 32 quarters since. 1,790 funds tracked by Wall St. Rank hold CME as of Q1 2026.

  • Lido Advisors held 18,230 shares of CME Group worth $5.39M as of Q1 2026.
  • Lido Advisors bought 1,529 CME Group shares in Q1 2026, an estimated $454K.
  • CME Group made up 0.02% of Lido Advisors's portfolio in Q1 2026, its #441 holding.
  • Lido Advisors first reported a position in CME Group in Q3 2017 and has held it in 32 quarters since.
  • 1,790 funds tracked by Wall St. Rank held CME Group as of Q1 2026.

Based on Lido Advisors's 13F filing for Q1 2026, filed 13 May 2026.